Kaiser Corporation Intrinsic Value

KACL • Commercial Services

Kaiser Corporation (KACL) median intrinsic value is ₹14.35 from 2 valuation models (range ₹11–₹14), vs current price ₹5.74 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. For current market price and key ratios, visit Kaiser Corporation stock price NSE .

Current Stock Price
₹5.74
Primary Intrinsic Value
₹14.35
Market Cap
₹2.9 Cr
+150.0% Upside
Median Value
₹14.35
Value Range
₹11 - ₹14
Assessment
Trading Below Calculated Value
Safety Margin
60.0%

KACL Valuation Methods Summary — DCF, Graham Number & P/E

Kaiser Corporation intrinsic value across 2 models vs current price ₹5.74 — upside/downside and value range per method. Browse KACL income statement for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹14.35 ₹12.91 - ₹15.79 +150.0% Book Value/Share: ₹18.00, P/B: 1.0x
Revenue Multiple Method revenue ₹11.48 ₹10.33 - ₹12.63 +100.0% Revenue/Share: ₹24.00, P/S: 0.8x
Method Types: Earnings Asset DCF Growth Dividend Conservative

KACL Intrinsic Value vs Market Price — All Valuation Models

Kaiser Corporation fair value range ₹11–₹14 vs current market price ₹5.74 across 2 valuation models. Compare with KACL fundamental valuation to assess whether the stock is under or overvalued.

KACL Intrinsic Value Analysis — Undervalued or Overvalued?

Kaiser Corporation median intrinsic value ₹14.35, current price ₹5.74 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.

What is the intrinsic value of KACL?

Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Kaiser Corporation (KACL) is ₹14.35 (median value). With the current market price of ₹5.74, this represents a +150.0% variance from our estimated fair value.

The valuation range spans from ₹11.48 to ₹14.35, indicating ₹11.48 - ₹14.35.

Is KACL undervalued or overvalued?

Based on our multi-method analysis, Kaiser Corporation (KACL) appears to be trading below calculated value by approximately 150.0%.

KACL Financial Health — Key Ratios vs Industry Benchmarks

Kaiser Corporation financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity -133.3% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin -67.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.32x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

KACL Cash Flow Quality — Operating & Free Cash Flow

Kaiser Corporation operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹-5 Cr ₹-5 Cr Negative Cash Flow 3/10
March 2024 ₹-1 Cr ₹-1 Cr Negative Cash Flow 3/10
March 2023 ₹-3 Cr ₹-4 Cr Negative Cash Flow 3/10
March 2022 ₹3 Cr ₹3 Cr Positive Free Cash Flow 8/10
March 2021 ₹-1 Cr ₹-1 Cr Negative Cash Flow 3/10